STOCKHOLM, SWEDEN (UroToday.com) - Presented by Michael Stöckle,1 Thomas Flaig,2 Carsten H. Ohlmann,1 Howard I. Scher,3 Johann S. de Bono,4 Dana E. Rathkopf,3 Charles J. Ryan,5 Thian Kheoh,6 Jinhui Li,7 Mary B. Todd,8 Thomas W. Griffin,6 Arturo Molina,9 and Karim Fizazi10 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
1Saarland University, Homburg/Saar, Germany; 2University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, CO, USA; 3Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA; 4The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK; 5Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA; 6Janssen Research & Development, Los Angeles, CA, USA; 7Janssen Research & Development, Raritan, NJ, USA; 8Janssen Global Services, Raritan, NJ, USA; 9Janssen Research & Development, Menlo Park, CA, USA; 10Institut Gustave Roussy, University of Paris Sud, Villejuif, France
Click HERE to read an exclusive report by a UroToday medical writer